Insights from 2023 ESMO Annual Meeting


 

ESMO 2023 Insights: "Nivo + Low Dose Ipi as 1L Therapy in Advanced GC or GEJ MSI-H Tumor - First Results of the NO LIMIT Study"

135 views
November 3, 2023
Comments 0
Login to view comments. Click here to Login